Abstract
Receptor tyrosine kinases (RTK) and the tumor suppressor PTEN co-regulate oncogenic cell signaling pathways. How these interactions influence gene transcription is inadequately understood. We used expression microarrays to investigate the effects of PTEN on gene expression changes caused by activating c-Met in human glioblastoma cells. c-Met activation by scatter factor/hepatocyte growth factor (SF/HGF) altered the expression of 27-fold more genes in PTEN-null U-373MG cells than in PTEN homozygous primary normal human astrocytes (523 vs 19 genes). Restoring wt-PTEN in U-373MG cells dramatically altered patterns of c-Met regulated gene expression. This effect was varied depending on the specific gene in question. PTEN reduced the number of c-Met regulated transcripts from 931 to 502, decreased the relative number of genes upregulated by c-Met from 46 to 25%, and increased the relative number of downregulated genes from 54 to 75%. PTEN and c-Met co-regulated many genes involved in cell growth regulation such as oncogenes, growth factors, transcription factors, and constituents of the ubiquitin pathway. c-Met activation in PTEN-null (but not PTEN reconstituted) cells led to upregulation of the EGFR agonist TGFα and subsequently to EGFR activation. Using PTEN mutants, we found that PTEN's transcriptional effects were either lipid-phosphatase dependent, protein-phosphatase dependent, or phosphatase-independent. These results show that PTEN has critical and mechanistically complex effects on RTK-regulated gene transcription. These findings expand our understanding of tumor promoter/suppressor inter-relationships and downstream transcriptional effects of PTEN loss and c-Met overexpression in malignant gliomas.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 50 print issues and online access
$259.00 per year
only $5.18 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Abounader R, Lal B, Luddy C, Koe G, Davidson B, Rosen EM and Laterra J . (2002). FASEB J., 16, 108–110.
Abounader R, Ranganathan S, Kim BY, Nichols C and Laterra J . (2001). J. Neurochem., 76, 1497–1508.
Abounader R, Ranganathan S, Lal B, Fielding K, Book A, Dietz H, Burger P and Laterra J . (1999). J. Natl. Cancer Inst., 91, 1548–1556.
Birchmeier C, Birchmeier W, Gherardi E and Vande Woude GF . (2003). Nat. Rev. Mol. Cell Biol., 4, 915–925.
Bowers DC, Fan S, Walter K, Abounader R, Williams JA, Rosen EM and Laterra J . (2000). Cancer Res., 60, 4277–4283.
Cheney IW, Johnson DE, Vaillancourt MT, Avanzini J, Morimoto A, Demers GW, Wills KN, Shabram PW, Bolen JB, Tavtigian SV and Bookstein R . (1998). Cancer Res., 58, 2331–2334.
Colantuoni C, Henry G, Zeger S and Pevsner J . (2002). Biotechniques, 32, 1316–1320.
Davies MP, Gibbs FE, Halliwell N, Joyce KA, Roebuck MM, Rossi ML, Salisbury J, Sibson DR, Tacconi L and Walker C . (1999). Br. J. Cancer, 79, 1542–1548.
DiRenzo MF, Narshimhan RP, Olivero M, Bretti S, Giordano S, Medico E, Gaglia P, Zara P and Comoglio PM . (1991). Oncogene, 6, 1997–2003.
Fujioka Y, Taira T, Maeda Y, Tanaka S, Nishihara H, Iguchi-Ariga SM, Nagashima K and Ariga H . (2001). J. Biol. Chem., 276, 45137–45144.
Gu J, Tamura M, Pankov R, Danen EH, Takino T, Matsumoto K and Yamada KM . (1999). J. Cell Biol., 146, 389–403.
He T-C, Zhou S, DaCosta LT, Yu J, Kinzler KW and Vogelstein B . (1998). Proc. Natl. Acad. Sci. USA, 95, 2509–2514.
Jeffers M, Schmidt L, Nakaigawa N, Webb CP, Weirich G, Kishida T, Zbar B and VandeWoude GF . (1997). Proc. Natl. Acad. Sci. USA, 21, 11445–11450.
Koochekpour S, Jeffers M, Rulong S, Taylor G, Klineberg E, Hudson EA, Resau JH and Vande Woude GF . (1997). Cancer Res., 57, 5391–5398.
Laterra J, Nam M, Rosen E, Rao JS and Johnston P . (1997). Lab. Invest., 76, 565–577.
Leslie NR, Bennett D, Gray A, Pass I, Hoang-Xuan K and Downes CP . (2001). Biochem. J., 357, 427–435.
Maehama T and Dixon JE . (1998). J. Biol. Chem., 273, 13375–13378.
Maier D, Jones G, Li X, Schonthal AH, Gratzl O, Van Meir EG and Merlo A . (1999). Cancer Res., 59, 5479–5482.
Raftopoulou M, Etienne-Manneville S, Self A, Nicholls S and Hall A . (2004). Science, 303, 1179–1181.
Rosen EM, Laterra J, Joseph A, Jin L, Fuchs A, Witte M, Weinarnd M and Goldberg ID . (1996). Intl. J. Cancer, 67, 248–255.
Sano T, Lin H, Chen X, Langford LA, Koul D, Bondy ML, Hess KR, Myers JN, Hong YK, Yung WK and Steck PA . (1999). Cancer Res., 59, 1820–1824.
Schaeper U, Gehring NH, Fuchs KP, Sachs M, Kempkes B and Birchmeier W . (2000). J. Cell Biol., 149, 1419–1432.
Stambolic V, MacPherson D, Sas D, Lin Y, Snow B, Jang Y, Benchimol S and Mak TW . (2001). Mol. Cell, 8, 317–325.
Stambolic V, Suzuki A, de la Pompa JL, Brothers GM, Mirtsos C, Sasaki T, Ruland J, Penninger JM, Siderovski DP and Mak TW . (1998). Cell, 95, 29–39.
Steck PA, Pershouse MA, Jasser SA, Yung WK, Lin H, Ligon AH, Langford LA, Baumgard ML, Hattier T, Davis T, Frye C, Hu R, Swedlund B, Teng DH and Tavtigian SV . (1997). Nat. Genet., 15, 356–362.
Teng DH, Hu R, Lin H, Davis T, Iliev D, Frye C, Swedlund B, Hansen KL, Vinson VL, Gumpper KL, Ellis L, El-Naggar A, Frazier M, Jasser S, Langford LA, Lee J, Mills GB, Pershouse MA, Pollack RE, Tornos C, Troncoso P, Yung WK, Fujii G, Berson A, Bookstein B, Bolen JB, Tavtigian SV and Steck PA . (1997). Cancer Res., 57, 5221–5225.
Wang SI, Puc J, Li J, Bruce JN, Cairns P, Sidransky D and Parsons R . (1997). Cancer Res., 57, 4183–4186.
Wu X, Senechal K, Neshat MS, Whang YE and Sawyers CL . (1998). Proc. Natl. Acad. Sci. USA, 95, 15587–15591.
Xiao GH, Jeffers M, Bellacosa A, Mitsuuchi Y, Vande Woude GF and Testa JR . (2001). Proc. Natl. Acad. Sci. USA, 98, 247–252.
Acknowledgements
Supported by NIH RO1 Grant NS045209 (Roger Abounader) and NIH ROI Grants NS032148 and NS43987 (John Laterra).
Author information
Authors and Affiliations
Corresponding authors
Rights and permissions
About this article
Cite this article
Abounader, R., Reznik, T., Colantuoni, C. et al. Regulation of c-Met-dependent gene expression by PTEN. Oncogene 23, 9173–9182 (2004). https://doi.org/10.1038/sj.onc.1208146
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.onc.1208146
Keywords
This article is cited by
-
MET-targeted therapy for gastric cancer: the importance of a biomarker-based strategy
Gastric Cancer (2016)
-
c-Met inhibitors
Infectious Agents and Cancer (2013)
-
Fibroblast-secreted hepatocyte growth factor mediates epidermal growth factor receptor tyrosine kinase inhibitor resistance in triple-negative breast cancers through paracrine activation of Met
Breast Cancer Research (2012)
-
Drug development of MET inhibitors: targeting oncogene addiction and expedience
Nature Reviews Drug Discovery (2008)
-
PTEN: a new guardian of the genome
Oncogene (2008)